Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study.
肿瘤科
队列
人口
危险系数
作者
Husam Abdel-Qadir,Nasruddin Sabrie,Darryl P. Leong,Andrea Pang,Peter C. Austin,Anca Prica,Kumaraswamy Nanthakumar,Oscar Calvillo-Argüelles,Douglas S. Lee,Paaladinesh Thavendiranathan
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology] 日期:2021-08-31卷期号:39 (31): 3453-3462被引量:1
标识
DOI:10.1200/jco.21.00693
摘要
PURPOSEIbrutinib reduces mortality in chronic lymphocytic leukemia (CLL). It increases the risk of atrial fibrillation (AF) and bleeding and there are concerns about heart failure (HF) and central ...